IFN-beta-1a vs Thymopentin
Head-to-head comparison of IFN-beta-1a (Recombinant human interferon beta-1a) and Thymopentin (L-Arginyl-L-Lysyl-L-Aspartyl-L-Valyl-L-Tyrosine) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | IFN-beta-1a | Thymopentin |
|---|---|---|
| Category | Immune Support | Immune Support |
| Full Name | Recombinant human interferon beta-1a | L-Arginyl-L-Lysyl-L-Aspartyl-L-Valyl-L-Tyrosine |
| Molecular Weight | ~22,500 Da | 676.78 Da |
| Half-Life | 10-19 hours | 10-30 min |
| Amino Acids | 166 | 5 |
| Typical Dose | 30-44 mcg per dose | 1 mg |
| Route | Intramuscular/Subcutaneous | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 1200 | 90 |
| Research Status | Clinical | Clinical |
IFN-beta-1a Benefits
- ✓antiviral gene induction
- ✓innate immune modulation
- ✓reduced viral replication
- ✓well-characterized safety profile
Thymopentin Benefits
- ✓t-cell maturation
- ✓helper-suppressor balance
- ✓immune recovery
- ✓antiviral-adjunct research
IFN-beta-1a Dosing
30 mcg intramuscular weekly or 44 mcg subcutaneous three times weekly|Titrate by indication and tolerability|Monitor liver enzymes, blood counts, and injection reactions
Thymopentin Dosing
1 mg SC or IM|2-3x weekly|4-8 week study cycles
IFN-beta-1a Side Effects
- ⚠flu-like symptoms
- ⚠injection-site reactions
- ⚠liver enzyme elevation
Thymopentin Side Effects
- ⚠injection-site redness
- ⚠mild fever
- ⚠headache
Research Overview
IFN-beta-1a
Widely studied recombinant interferon beta preparation with a strong evidence base in immune modulation and antiviral biology. Its clinical use demonstrates predictable pharmacology and class-typical interferon effects.
Thymopentin
Thymopentin has a long history of preclinical and clinical investigation as a thymic peptide immunomodulator. Published studies report effects on T-cell subsets, cytokine responses, and immune recovery in recurrent infection settings.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.